Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

PCR primer used for building library for chromaffin cell pathogenic gene next generation sequencing and library building method

A disease-causing gene and chromaffin cell technology, applied in the field of molecular biology, can solve problems such as restricting the development of technology and research, and achieve the effect of low cost and good uniformity

Active Publication Date: 2017-10-31
SHANGHAI INST FOR ENDOCRINE & METABOLIC DISEASES
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Regardless of the existing PCR amplification or probe probe, it is mainly occupied by foreign manufacturers at present. If relevant experiments are to be done, the gene to be done must be provided to the corresponding company, for example: life technology, illumina and other foreign countries companies, and then these foreign companies design and synthesize the corresponding reagents, and then sell them to domestic manufacturers, which greatly restricts the development and research of domestic related technologies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PCR primer used for building library for chromaffin cell pathogenic gene next generation sequencing and library building method
  • PCR primer used for building library for chromaffin cell pathogenic gene next generation sequencing and library building method
  • PCR primer used for building library for chromaffin cell pathogenic gene next generation sequencing and library building method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0029] This embodiment relates to a method for building a library for next-generation sequencing of chromaffin cell pathogenic genes, including the following steps:

[0030]1. Using the extracted human genomic DNA as a template for PCR amplification

[0031] 2. The conditions and primers for PCR amplification are as follows:

[0032] Reaction system (take 50ul as an example):

[0033]

[0034] PCR reaction conditions: pre-denaturation at 95°C for 5-10 minutes, denaturation at 95°C for 15-30s, annealing at 56-64°C for 15-60s, extension at 72°C for 15-60s, and a total of 20-35 cycles of denaturation, annealing and extension.

[0035] The formulation of the above 10×amplification buffer can be selected: 100mM Tris-HCl, pH 8.3at 25°C, 500mM KCl, 25mM MgCl2, 10mM EDTA, 1mM Tween20.

[0036] The primer sequences are shown in Table 1:

[0037] Table 1

[0038]

[0039]

[0040]

[0041]

[0042] 3. Recover the amplified PCR fragments and perform sequencing to build...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a PCR primer used for building a library for chromaffin cell pathogenic gene next generation sequencing and a library building method, wherein the PCR primer is selected from nucleotides shown in SEQ ID NO:1-SEQ ID NO:70; and chromaffin cell pathogenic genes are SDHB, SDHC, SDHD, MAX, VHL, TMEM127 and RET. The library building method comprises the following steps: utilizing extracted human genome DNA as a template, adopting the primer as a specific amplification part of the primer to carry out first-round PCR amplification; diluting a product of the-first PCR amplification as a template of second-round PCR amplification; carrying out the second-round PCR amplification, namely carrying out another round of amplification by utilizing a universal primer of the first-round PCR amplification, and adding index required by a sequencing machine and a base sequence used for identifying the sequencing machine in a specific primer identification zone; and purifying a second-round sequencing product with nucleic acid, so that the second-round sequencing product can be subjected to sequencing on the sequencing machine. The library building method disclosed by the invention is designed and developed self and is extremely low in cost compared with a purchased foreign kit.

Description

technical field [0001] The invention belongs to the field of molecular biology, and in particular relates to a PCR primer and a library building method for second-generation sequencing of a chromaffin cell pathogenic gene. Background technique [0002] DNA sequencing has become an indispensable and important technology in biological research, fundamentally changing the way people study the blueprint of life. With the optimization of sequencing platform hardware and corresponding software, it is not the sequencing technology itself that hinders the progress of research, but the library construction and data analysis and interpretation related to it. [0003] 454 Life Sciences (Roche) first launched a revolutionary ultra-high-throughput genome sequencing system based on pyro-sequencing, pioneering the second-generation sequencing technology. Next-generation sequencing is also called high-throughput sequencing technology, and the basic principle is to synthesize and sequence a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68C40B50/06C12N15/11
CPCC12Q1/6869C12Q1/6883C40B50/06C12Q2531/113
Inventor 宁光崔斌王卫庆苏颋为蒋怡然周薇薇齐研朱巍张翠
Owner SHANGHAI INST FOR ENDOCRINE & METABOLIC DISEASES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products